Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-02-21 | 2024-02-21 |
| Drug Identification Number | 02494574 | 02494574 |
| Brand name | CLADRIBINE INJECTION | CLADRIBINE INJECTION |
| Common or Proper name | CLADRIBINE INJECTION | CLADRIBINE INJECTION |
| Company Name | GENERIC MEDICAL PARTNERS INC | GENERIC MEDICAL PARTNERS INC |
| Ingredients | CLADRIBINE | CLADRIBINE |
| Strength(s) | 1MG | 1MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 1mg/ml 10ml Vial | 1mg/ml 10ml Vial |
| ATC code | L01BB | L01BB |
| ATC description | ANTIMETABOLITES | ANTIMETABOLITES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2024-01-25 | 2024-01-25 |
| Actual start date | 2024-01-25 | 2024-01-25 |
| Estimated end date | 2024-02-26 | 2024-02-26 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | It was expected that GMP Cladribine 1mg/ml 10 ml vials would be available for sale from mid-February 2024. A short delay will occur before GMP Cladribine 1mg/ml 10 ml vials will be released. It is now expected that stock will be available for sale from February 26 2024. A communication will be issued on the actual day of release. | It was expected that GMP Cladribine 1mg/ml 10 ml vials would be available for sale from mid-February 2024. A short delay will occur before GMP Cladribine 1mg/ml 10 ml vials will be released. It is now expected that stock will be available for sale from February 26 2024. A communication will be issued on the actual day of release. |
| Health Canada comments |